Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (471-480 of 563) with videos related to

Pageof 57
Sort By:
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Antiviral Research|August 1, 1997
Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variationC McGuigan, H W Tsang, D Cahard, et al.
Journal of Virology|October 29, 1997
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1H Pelemans, R Esnouf, A Dunkler, et al.
The Journal of Antibiotics|June 1, 1992
Amides of antibiotic streptonigrin and amino dicarboxylic acids or aminosugars. Synthesis and biological evaluationV V Tolstikov, N V Kozlova, T D Oreshkina, et al.
Biochemical and Biophysical Research Communications|October 30, 1986
Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidineJ Balzarini, R Pauwels, P Herdewijn, et al.
Journal of Virology|July 10, 1999
Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replicationH F Egberink, E De Clercq, A L Van Vliet, et al.
The Journal of Infectious Diseases|November 1, 1993
Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDSR Snoeck, M Gérard, C Sadzot-Delvaux, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
"Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strainsE Lobatón, S Velázquez, M J Pérez-Pérez, et al.
Antiviral Chemistry & Chemotherapy|September 10, 1999
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsA Chimirri, S Grasso, P Monforte, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitorsS Manfredini, P G Baraldi, E Durini, et al.
Pageof 57

Showing results (471-480 of 563) with videos related to

Sort By:
Pageof 57
Biochemical Pharmacology|June 1, 1987
Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivityD A Cooney, G Ahluwalia, H Mitsuya, et al.
Antiviral Research|August 1, 1997
Phosphoramidate derivatives of d4T as inhibitors of HIV: the effect of amino acid variationC McGuigan, H W Tsang, D Cahard, et al.
Journal of Virology|October 29, 1997
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1H Pelemans, R Esnouf, A Dunkler, et al.
The Journal of Antibiotics|June 1, 1992
Amides of antibiotic streptonigrin and amino dicarboxylic acids or aminosugars. Synthesis and biological evaluationV V Tolstikov, N V Kozlova, T D Oreshkina, et al.
Biochemical and Biophysical Research Communications|October 30, 1986
Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidineJ Balzarini, R Pauwels, P Herdewijn, et al.
Journal of Virology|July 10, 1999
Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replicationH F Egberink, E De Clercq, A L Van Vliet, et al.
The Journal of Infectious Diseases|November 1, 1993
Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDSR Snoeck, M Gérard, C Sadzot-Delvaux, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
"Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strainsE Lobatón, S Velázquez, M J Pérez-Pérez, et al.
Antiviral Chemistry & Chemotherapy|September 10, 1999
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsA Chimirri, S Grasso, P Monforte, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2001
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitorsS Manfredini, P G Baraldi, E Durini, et al.
Pageof 57